Tinostamustine–nivolumab therapy is associated with antigen-specific cellular and humoral immune responses in heavily pre-treated patients with advanced melanoma
- DOI
- 10.1007/s00262-026-04608-4
- Published
- 2026-11-05
- Container
- Cancer Immunology, Immunotherapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00262-026-04608-4,
title = {Tinostamustine–nivolumab therapy is associated with antigen-specific cellular and humoral immune responses in heavily pre-treated patients with advanced melanoma},
author = {Shrunal Mane and Vincent Walter and Marie-Therese Abdou and Stefan Diem and Nina Wyss and Kira-Lee Koster and Lenka Besse and Dagmar Hess and Yannis Metaxas and Marie-Claire Flynn and Stefanie Aeppli and Taemer El Saadany and Elke Hiendlmeyer and Roger von Moos and Markus Joerger and Lukas Flatz},
year = {2026},
journal = {Cancer Immunology, Immunotherapy},
doi = {10.1007/s00262-026-04608-4},
url = {https://doi.org/10.1007/s00262-026-04608-4}
}RIS
TY - JOUR TI - Tinostamustine–nivolumab therapy is associated with antigen-specific cellular and humoral immune responses in heavily pre-treated patients with advanced melanoma AU - Shrunal Mane AU - Vincent Walter AU - Marie-Therese Abdou AU - Stefan Diem AU - Nina Wyss AU - Kira-Lee Koster AU - Lenka Besse AU - Dagmar Hess AU - Yannis Metaxas AU - Marie-Claire Flynn AU - Stefanie Aeppli AU - Taemer El Saadany AU - Elke Hiendlmeyer AU - Roger von Moos AU - Markus Joerger AU - Lukas Flatz PY - 2026 JO - Cancer Immunology, Immunotherapy DO - 10.1007/s00262-026-04608-4 UR - https://doi.org/10.1007/s00262-026-04608-4 ER -
APA
Mane, S., Walter, V., Abdou, M., Diem, S., Wyss, N., Koster, K., Besse, L., Hess, D., Metaxas, Y., Flynn, M., Aeppli, S., Saadany, T. E., Hiendlmeyer, E., Moos, R. V., Joerger, M., & Flatz, L. (2026). Tinostamustine–nivolumab therapy is associated with antigen-specific cellular and humoral immune responses in heavily pre-treated patients with advanced melanoma. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04608-4
Source records
- crossref · retrieved 2026-11-08T06:34:31.815Z